Bruce P. Damiano - Concepedia

Author

Bruce P. Damiano

Also Known As

B Damiano, B P Damiano, B. P. Damiano, B.P. Damiano, Bruce Damiano, Bruce P Damiano, Bruce P. Damiano, Bruce P. Damiano, Damiano, B.P., Michael D’Andrea

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Springhouse Janssen (United States)Penn State Milton S. Hershey Medical Center

About

Bruce P. Damiano is an author at Johnson & Johnson (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	35	1.8K
2	Natural Sciences	12	12	677
3	Health Sciences	5	5	469
4	Social Sciences	3	3	382
5	Engineering	1	1	12

Bruce P. Damiano

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Effects of pacing on triggered activity induced by early afterdepolarizations. Bruce P. Damiano, Michael R. Rosen Circulation Cesium ChlorideCardiac MuscleBiofeedbackMotor ControlBiomedical Engineering	1984	257
Cardiovascular Responses Mediated by Protease-Activated Receptor-2 (PAR-2) and Thrombin Receptor (PAR-1) are Distinguished in Mice Deficient in PAR-2 or PAR-1 Bruce P. Damiano, Wai Cheung, Rosemary J. Santulli, Journal of Pharmacology and Experimental Therapeutics	1999	182
Sustained electrical stimulation of the perforant path duplicates kainate-induced electrophysiological effects and hippocampal damage in rats Robert S. Sloviter, Bruce P. Damiano Neuroscience Letters Synaptic PlasticityNeuromodulation (Medicine)NeurophysiologyNeuroanatomySynaptic Transmission	1981	176
Biological Consequences of Thrombin Receptor Deficiency in Mice Andrew L. Darrow, Wai‐Ping Fung‐Leung, Richard D. Ye, Thrombosis and Haemostasis	1996	163
Blockade of the Thrombin Receptor Protease-Activated Receptor-1 with a Small-Molecule Antagonist Prevents Thrombus Formation and Vascular Occlusion in Nonhuman Primates Claudia K. Derian, Bruce P. Damiano, Andrew L. Darrow, Journal of Pharmacology and Experimental Therapeutics	2003	159
On the relationship between kainic acid-induced epileptiform activity and hippocampal neuronal damage Robert S. Sloviter, Bruce P. Damiano Neuropharmacology NeurophysiologyPhysiologyHippocampal Neuronal DamageNeuropharmacologyNeuroprotection	1981	150
Altered Vascular Injury Responses in Mice Deficient in Protease-Activated Receptor-1 Wai-man Cheung, Michael R. D’Andrea, Patricia Andrade‐Gordon, Arteriosclerosis Thrombosis and Vascular Biology	1999	118
Administration of a Potent Antagonist of Protease-Activated Receptor-1 (PAR-1) Attenuates Vascular Restenosis Following Balloon Angioplasty in Rats Patricia Andrade‐Gordon, Claudia K. Derian, Bruce E. Maryanoff, Journal of Pharmacology and Experimental Therapeutics	2001	112
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA <i>In Silico</i> Strategy Zhihua Li, Gary R. Mirams, Takashi Yoshinaga, Clinical Pharmacology & Therapeutics	2019	106
Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3 Han‐Cheng Zhang, Llorente V. R. Boñaga, Hong Ye, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryNatural SciencesMaleimide Pyridinophanes	2007	94

Page 1